KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Non Operating Income (2016 - 2025)

Zimmer Biomet Holdings has reported Non Operating Income over the past 12 years, most recently at $15.4 million for Q4 2025.

  • Quarterly results put Non Operating Income at $15.4 million for Q4 2025, up 140.42% from a year ago — trailing twelve months through Dec 2025 was $25.5 million (up 181.99% YoY), and the annual figure for FY2025 was $25.5 million, up 181.99%.
  • Non Operating Income for Q4 2025 was $15.4 million at Zimmer Biomet Holdings, up from $3.3 million in the prior quarter.
  • Over the last five years, Non Operating Income for ZBH hit a ceiling of $15.4 million in Q4 2025 and a floor of -$56.1 million in Q1 2022.
  • Median Non Operating Income over the past 5 years was $1.2 million (2021), compared with a mean of -$6.5 million.
  • Biggest five-year swings in Non Operating Income: plummeted 8566.67% in 2022 and later skyrocketed 3000.0% in 2025.
  • Zimmer Biomet Holdings' Non Operating Income stood at -$3.8 million in 2021, then decreased by 2.63% to -$3.9 million in 2022, then tumbled by 402.56% to -$19.6 million in 2023, then crashed by 94.39% to -$38.1 million in 2024, then soared by 140.42% to $15.4 million in 2025.
  • The last three reported values for Non Operating Income were $15.4 million (Q4 2025), $3.3 million (Q3 2025), and $3.9 million (Q2 2025) per Business Quant data.